CRESTLINE MANAGEMENT, LP – Reata Pharmaceuticals, Inc. Transaction History
CRESTLINE MANAGEMENT, LP portfolio value:
$933,000
portfolio value
CRESTLINE MANAGEMENT, LP quarter portfolio value change:
-17.31%
quarter
Reata Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +38.94% | 10.4K shares | 121K | $25.13 | 37.10K |
Q2 2022 | share | Increase | +104.08% | 13.62K shares | 383K | $30.39 | 26.70K |
Q1 2022 | share | Increase | 0.00% | 13.08K shares | 429K | $32.76 | 13.08K |
Q4 2021 | share | Decrease | -100.00% | -5.90K shares | -594K | $26.38 | 0 |
Q3 2021 | share | Decrease | -1.71% | -103 shares | -257K | $100.61 | 5.90K |
Q2 2021 | share | Increase | 0.00% | 6.01K shares | 851K | $141.53 | 6.01K |
Q3 2018 | share | Decrease | -100.00% | -26.43K shares | -925K | $81.76 | 0 |
Q2 2018 | share | Decrease | -70.18% | -62.23K shares | -894K | $34.97 | 26.43K |
Q1 2018 | share | Increase | +28.69% | 19.76K shares | -132K | $20.51 | 88.67K |
Q4 2017 | share | Increase | +13.96% | 8.44K shares | 71K | $28.32 | 68.90K |
Q3 2017 | share | Increase | 0.00% | 60.46K shares | 1.88M | $31.1 | 60.46K |